Study That Examines the Mental and Behavioral Outcomes in Younger Patients With Cancer
Neuropsychological, Social, Emotional, and Behavioral Outcomes in Children with Cancer
-
Clinical Trial Information
Trial Contact: Spinelli, Jennifer; Parker, Melanie; Armatti, Julie M; Doyle, Katherine M; Dubberly, Paige D
Trial Phone: 321.841.5357 ; 321-843-1036 ; 321-843-5284 ; 3218412008 ; 321-841-7561
-
IRB No: ALTE07C1
Protocol Abbrev: ALTE07C1
Principal Investigator: Amy A. Smith, MD
Age Group: Pediatric
Secondary Protocol No: ALTE07C1
Treatment: Procedure: psychosocial assessment and care Procedure: cognitive assessment Other: quality-of-life assessment Other: questionnaire administration
ClinicalTrials.gov ID: NCT00772200
-
Objective
This research trial studies neuropsychological (learning, remembering or thinking) and behavioral testing in younger patients with cancer.
-
Key Eligibility
Eligibility
Ages Eligible for Study: 1 Month to 21 Years
Genders Eligible for Study: Both
Accepts Healthy Volunteers: No
Sampling Method: Non-Probability Sample
Study Population
Patients on COG Phase III clinical trials.
Criteria
Inclusion Criteria:
• The patient must be currently be enrolled or plan to be enrolled on a COG therapeutic study that aims to examine neuropsychological, social, emotional, and/or behavioral functioning
• The patient must have receptive and expressive English language skills
